Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

AMGN Amgen Inc

Price (delayed)

$265.86

Market cap

$142.95B

P/E Ratio

24.06

Dividend/share

$9.13

EPS

$11.05

Enterprise value

$191.53B

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. ...

Highlights
The net income has soared by 58% YoY and by 45% from the previous quarter
AMGN's EPS has surged by 57% year-on-year and by 45% since the previous quarter
AMGN's gross margin is down by 5% year-on-year but it is up by 2.4% since the previous quarter
AMGN's quick ratio is down by 12% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of AMGN
Market
Shares outstanding
537.71M
Market cap
$142.95B
Enterprise value
$191.53B
Valuations
Price to earnings (P/E)
24.06
Price to book (P/B)
23.01
Price to sales (P/S)
4.19
EV/EBIT
19.74
EV/EBITDA
12.53
EV/Sales
5.61
Earnings
Revenue
$34.13B
Gross profit
$21.5B
Operating income
$7.45B
Net income
$5.93B
EBIT
$9.7B
EBITDA
$15.28B
Free cash flow
$10.92B
Per share
EPS
$11.05
EPS diluted
$10.96
Free cash flow per share
$20.29
Book value per share
$11.55
Revenue per share
$63.43
TBVPS
$83.64
Balance sheet
Total assets
$89.37B
Total liabilities
$83.16B
Debt
$57.38B
Equity
$6.21B
Working capital
$3.92B
Liquidity
Debt to equity
9.24
Current ratio
1.17
Quick ratio
0.74
Net debt/EBITDA
3.18
Margins
EBITDA margin
44.8%
Gross margin
63%
Net margin
17.4%
Operating margin
21.8%
Efficiency
Return on assets
6.5%
Return on equity
92.9%
Return on invested capital
13.4%
Return on capital employed
14.6%
Return on sales
28.4%
Dividend
Dividend yield
3.43%
DPS
$9.13
Payout ratio
82.6%

AMGN stock price

How has the Amgen stock price performed over time
Intraday
-2.28%
1 week
-5.46%
1 month
-8.67%
1 year
-15.02%
YTD
2%
QTD
-14.67%

Financial performance

How have Amgen's revenue and profit performed over time
Revenue
$34.13B
Gross profit
$21.5B
Operating income
$7.45B
Net income
$5.93B
Gross margin
63%
Net margin
17.4%
The net income has soared by 58% YoY and by 45% from the previous quarter
The net margin rose by 43% since the previous quarter and by 37% year-on-year
The revenue has grown by 16% year-on-year and by 2.1% since the previous quarter
The gross profit has increased by 10% year-on-year and by 4.5% since the previous quarter

Price vs fundamentals

How does AMGN's price correlate with its fundamentals

Growth

What is Amgen's growth rate over time

Valuation

What is Amgen stock price valuation
P/E
24.06
P/B
23.01
P/S
4.19
EV/EBIT
19.74
EV/EBITDA
12.53
EV/Sales
5.61
AMGN's EPS has surged by 57% year-on-year and by 45% since the previous quarter
The P/E is 39% below the last 4 quarters average of 39.2 and 3.8% below the 5-year quarterly average of 25.0
Amgen's equity has increased by 24% YoY and by 6% from the previous quarter
The stock's price to book (P/B) is 23% less than its 5-year quarterly average of 29.8 and 10% less than its last 4 quarters average of 25.5
The P/S is 18% less than the 5-year quarterly average of 5.1 and 16% less than the last 4 quarters average of 5.0
The revenue has grown by 16% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Amgen business performance
AMGN's return on assets has surged by 59% year-on-year and by 44% since the previous quarter
The ROE has soared by 59% YoY and by 38% from the previous quarter
The ROIC has grown by 34% YoY and by 28% from the previous quarter
AMGN's return on sales is up by 22% since the previous quarter and by 12% year-on-year

Dividends

What is AMGN's dividend history
DPS
$9.13
Dividend yield
3.43%
Payout ratio
82.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Amgen financials performed over time
Amgen's total assets is 7% more than its total liabilities
Amgen's current ratio has decreased by 18% YoY and by 7% from the previous quarter
AMGN's quick ratio is down by 12% year-on-year and by 9% since the previous quarter
AMGN's debt to equity is down by 28% YoY and by 10% QoQ
Amgen's equity has increased by 24% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.